RNS Number : 8095I
Legal & General UCITS ETF PLC
03 April 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
03/04/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
108334570.31 |
9.206 |
| L&G UK Equity UCITS ETF |
03/04/2020 |
IE00BFXR5R48 |
1000000 |
GBP |
8048083.54 |
8.048 |
| L&G Global Equity UCITS ETF |
03/04/2020 |
IE00BFXR5S54 |
2800000 |
USD |
25243294.00 |
9.015 |
| L&G Japan Equity UCITS ETF |
03/04/2020 |
IE00BFXR5T61 |
11305000 |
USD |
99660136.19 |
8.816 |
| L&G Europe ex UK Equity UCITS ETF |
03/04/2020 |
IE00BFXR5V83 |
9260988 |
EUR |
83473022.11 |
9.013 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
03/04/2020 |
IE00BFXR5W90 |
3700000 |
USD |
31078221.48 |
8.400 |
| L&G Clean Water UCITS ETF |
03/04/2020 |
IE00BK5BC891 |
1250000 |
USD |
10318200.27 |
8.255 |
| L&G Artificial Intelligence UCITS ETF |
03/04/2020 |
IE00BK5BCD43 |
900000 |
USD |
7454950.10 |
8.283 |
| L&G Healthcare Innovation UCITS ETF |
03/04/2020 |
IE00BK5BC677 |
1250000 |
USD |
11466761.37 |
9.173 |
| L&G Pharma Breakthrough UCITS ETF |
03/04/2020 |
IE00BF0H7608 |
850000 |
USD |
7794965.55 |
9.171 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
03/04/2020 |
IE00BKLTRN76 |
9100000 |
EUR |
78063413.40 |
8.578 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
03/04/2020 |
IE00BKLWY790 |
51300000 |
USD |
421447371.70 |
8.215 |
| L&G Battery Value-Chain UCITS ETF |
03/04/2020 |
IE00BF0M2Z96 |
7150000 |
USD |
47376748.23 |
6.626 |
| L&G Ecommerce Logistics UCITS ETF |
03/04/2020 |
IE00BF0M6N54 |
1000000 |
USD |
8003384.67 |
8.003 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
03/04/2020 |
IE00BMW3QX54 |
47830616 |
USD |
600831352.63 |
12.562 |
| L&G Cyber Security UCITS ETF |
03/04/2020 |
IE00BYPLS672 |
74191776 |
USD |
1027678309.95 |
13.852 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVKZGGDZFMGGZZ
